Public-sector Contributions to Novel Biologic Drugs

This cohort study investigates downstream public-sector support for the creation of new biologic drugs by examining their patent and drug development histories.

Gardado en:
Detalles Bibliográficos
Publicado en:JAMA Intern Med
Main Authors: Nayak, Rahul K., Lee, ChangWon C., Avorn, Jerry, Kesselheim, Aaron S.
Formato: Artigo
Idioma:Inglês
Publicado: American Medical Association 2021
Assuntos:
Research Letter
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8290329/
https://ncbi.nlm.nih.gov/pubmed/34279545
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamainternmed.2021.3720
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares